This is the authors' abstract. We don't add key points for this paper.
The therapeutic arsenal against bacterial infections is rapidly shrinking, as drug resistance spreads and pharmaceutical industry are struggling to produce new antibiotics. In this review we cover the efficacy of silver as an antibacterial agent. In particular we recall experimental evidences pointing to the multiple targets of silver, including DNA, proteins and small molecules, and we review the arguments for and against the hypothesis that silver acts by enhancing oxidative stress. We also review the recent use of silver as an adjuvant for antibiotics. Specifically, we discuss the state of our current understanding on the potentiating action of silver ions on aminoglycoside antibiotics.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Barras et al. (2018) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: